Company: SXTPW
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001213900-25-043779
Chunk: 100

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 8
Chunk 100
---
 cash fees, the Company issued the Placement Agent warrants to purchase up to 22,554
shares of common stock at an exercise price of $4.469 (the “February 2025 Agent Warrants”). The February 2025 Agent Warrants
were exercisable upon issuance and expire twenty-four months from the date of issuance.

January 2024 Offering

On January 29, 2024, the Company closed its public
offering (the “January 2024 Offering”) consisting of (i) 87,682 units consisting of one share of common stock and one warrant
exercisable for one share of common stock (the “January 2024 Warrants”), and (ii) 16,652 pre-funded units consisting of one
pre-funded warrant exercisable for one share of common stock (the “January 2024 Pre-Funded Warrants”) and one warrant identical
to the January 2024 Warrants included in the units. The January 2024 Pre-Funded Warrants have an exercise price of $0.60 per share and
were immediately exercisable until exercised in full. The January 2024 Warrants have an exercise price of $25.41 per share, were immediately
exercisable upon issuance, and expire on January 31, 2029. The January 2024 Offering closed on January 31, 2024, generating net proceeds
to the Company of approximately $1.9 million, after deducting underwriting discounts and commissions and the payment of other offering
expenses payable by the Company of approximately $510,000.

The Company granted WallachBeth Capital LLC a
45-day over-allotment option to purchase additional shares of common stock, additional January 2024 Warrants, or additional January 2024
Pre-Funded Warrants, or any combination thereof. WallachBeth Capital LLC partially exercised its over-allotment option with respect to
13,637 January 2024 Warrants on January 31, 2024, and an additional one share of common stock and one January 2024 Warrant on February
14, 2024.

The Company also issued to WallachBeth Capital
LLC warrants (the “January 2024 Representative Warrants”) to purchase 6,260 shares of the Company’s common stock at
an exercise price of $25.41 per share. The January 2024 Representative Warrants were immediately exercisable beginning on January 31,
2024 until January 31,